Jared M. Baeten

机构：University of Washington, Gilead Sciences (United States) · ORCID：0000-0001-8242-8438

发表论文 705 篇 · 总被引 34203 次 · h-index 91

代表论文

• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 261)
• Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences (2025 · Clinical Infectious Diseases · 被引 12)
• Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 (2025 · Annals of Internal Medicine · 被引 9)
• Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trial (2024 · The Lancet HIV · 被引 9)
• 577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir (2025 · Open Forum Infectious Diseases · 被引 6)
• Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 study (2026 · The Lancet Microbe · 被引 5)